UFP Technologies Inc. | Small-cap | Healthcare
$241.07
-3.42%
| UFP Technologies Stock Comparison:
UFP Technologies vs Abbott LaboratoriesUFP Technologies vs Boston ScientificUFP Technologies vs Alphatec HoldingsUFP Technologies vs NovocureUFP Technologies vs EnovisUFP Technologies vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 504.4M
Gross Profit 146.7M 29.08%
Operating Income 84.5M 16.75%
Net Income 59.0M 11.69%

Balance Sheet Metrics

Total Assets 629.0M
Total Liabilities 286.2M
Shareholders Equity 342.8M
Debt to Equity 0.84

Cash Flow Metrics

Operating Cash Flow 66.9M
Free Cash Flow 56.9M

Revenue & Profitability Trend

UFP Technologies Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue504.4M400.1M353.8M206.3M179.4M
Cost of Goods Sold357.7M287.8M263.5M155.2M134.7M
Gross Profit146.7M112.2M90.3M51.1M44.7M
Operating Expenses62.2M50.9M45.8M29.5M27.5M
Operating Income84.5M61.3M44.5M21.6M17.2M
Pre-tax Income73.0M53.9M52.7M21.2M16.3M
Income Tax14.0M9.0M10.9M5.3M2.9M
Net Income59.0M44.9M41.8M15.9M13.4M
EPS (Diluted)-$5.83$5.45$2.09$1.77

Income Statement Trend

UFP Technologies Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets194.9M144.6M116.3M87.3M71.9M
Non-Current Assets434.0M259.5M261.8M246.8M131.3M
Total Assets629.0M404.1M378.2M334.1M203.2M
Liabilities
Current Liabilities76.3M58.2M56.0M38.8M15.1M
Non-Current Liabilities209.9M59.8M84.7M100.9M11.2M
Total Liabilities286.2M118.0M140.6M139.7M26.3M
Equity
Total Shareholders Equity342.8M286.1M237.5M194.4M176.9M

Balance Sheet Composition

UFP Technologies Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income59.0M44.9M41.8M15.9M13.4M
Operating Cash Flow66.9M42.1M29.8M13.9M25.4M
Investing Activities
Capital Expenditures-9.6M-10.5M21.9M-5.3M-4.3M
Investing Cash Flow-207.1M-10.5M1.3M-101.5M-4.3M
Financing Activities
Dividends Paid-----
Financing Cash Flow152.2M-30.7M-26.3M73.9M-6.3M
Free Cash Flow56.9M30.8M4.0M8.9M20.7M

Cash Flow Trend

UFP Technologies Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 29.89
Forward P/E 28.36
Price to Book 5.20
Price to Sales 3.42
PEG Ratio 28.36

Profitability Ratios

Profit Margin 11.59%
Operating Margin 15.81%
Return on Equity 19.36%
Return on Assets 10.92%

Financial Health

Current Ratio 2.58
Debt to Equity 55.05
Beta 1.12

Per Share Data

EPS (TTM) $8.14
Book Value per Share $46.80
Revenue per Share $71.32

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
ufpt1.9B29.895.2019.36%11.59%55.05
Abbott Laboratories 231.9B17.314.7530.65%31.89%27.09
Boston Scientific 149.9B73.946.759.50%11.58%52.16
Alphatec Holdings 1.6B-9.63-18.581,144.21%-25.77%-6.76
Novocure 1.9B-10.905.12-45.52%-26.41%192.49
Enovis 1.7B-2.010.66-27.35%-37.65%55.68

Financial data is updated regularly. All figures are in the company's reporting currency.